Introducing Pharmaceutical copy approval.

The pharmaceutical industry, which is known for its stringent regulations and meticulous attention to detail, particularly in the approval of promotional and non-promotional materials, places significant emphasis on the copy approval process. This process, a pivotal component of pharmaceutical operations, is designed to ensure compliance with regulatory standards, maintain the integrity of information, and uphold the industry’s reputation. Therefore, pharmaceutical companies cannot overstate its importance, as it is a key factor in bringing products to market efficiently and ethically.

Adherence to guidelines.

At the heart of the copy approval process is the need to adhere to the guidelines set forth by regulatory bodies such as the Prescription Medicines Code of Practice Authority (PMCPA) and the Medicines and Healthcare Products Regulatory Agency (MHRA). These organisations mandate that all promotional materials undergo rigorous review and certification to ensure they meet the highest standards of accuracy and compliance. The PMCPA’s Guidance on Certification emphasises that certification is typically the final step involving multiple reviews by various staff members before final approval. This multi-layered approach can catch errors or inconsistencies that could lead to code breaches and subsequent sanctions.

Primary challenges in copy approval.

One of the primary challenges in the copy approval process is the sheer volume of materials that need reviewing. From origination to uploading, review, certification, and archiving, each step requires meticulous attention to detail and a thorough understanding of regulatory requirements. Fundamental errors in this process can have serious consequences, as evidenced by past cases where companies faced sanctions due to flaws in their copy approval systems. To mitigate these challenges, the industry has seen the introduction of Appropriately Qualified Persons (AQPs) under the new ABPI Code of Practice. This pragmatic move aims to reduce the approval burden on signatories and streamline the process. For example, AQPs can now check printed materials against the final certified electronic version. Whilst, the previous argument was that this talk is more of an identity check than a compliance one. Additionally, AQPs can certify meeting arrangements for UK health professionals travelling to overseas meetings, further alleviating the workload of medical signatories.

Digital tools for copy approval.

Despite these advancements, the copy approval process remains complex and often lengthy. The introduction of digital tools and paperless validation systems has brought about significant changes, offering new ways to handle verification and validation while maintaining compliance with current regulations. Authentic Copy Verification practices, for instance, ensure that electronic copies of original documentation preserve the same content, meaning, and attributes as the original. This process involves second-person verification to compare the electronic copy to the original, a requirement that varies depending on the risk associated with the data. While some guidelines necessitate second-person verification for critical data transcription, others allow for sufficient control of risk through the checks in the Commissioning and Qualification (C&Q) process. The complexity of the copy approval process is further compounded by the need to stay abreast of evolving regulatory standards and guidelines.

Keeping informed about regulatory guidelines.

The ethical standards and regulatory guidelines that govern the industry are constantly evolving, differ nationally and require continuous vigilance and adaptation. In a global, connected digital world, where information is not governed by national borders and needs to be current and up to the minute, companies are faced with complex challenges to meet their business needs, the expectations of their customers but also remain compliant. The most common activity that brings companies into the frame of the UK governing body, the PMCPA, is the interaction with Company news by employees on their social media accounts, accounting for up to half of all cases processed in 2024.

So, getting a copy approved in the pharmaceutical world is quite an adventure. You need to pay close attention to every little detail, follow all the regulatory rules to the letter, and keep up with the constantly changing landscape. It’s like navigating a maze, but you can make it through successfully with the right approach. While advancements such as introducing AQPs and digital tools have helped streamline specific aspects of the process, the inherent complexities remain a significant challenge. By recognising these challenges and implementing best practices, pharmaceutical companies can better navigate the intricacies of copy approval, ensuring compliance, maintaining high standards, and ultimately bringing safe and effective products to market.

Explore our website here to learn more about My Medical Department and how we can support your organisation.